BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14714857)

  • 1. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
    Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
    Samanta S; Pain A; Dutta S; Sanyal U
    Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
    J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
    Samanta S; Pain A; Dutta S; Sanyal U
    J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
    Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
    Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
    Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
    Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
    J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
    Gupta R; Liu J; Xie G; Lown JW
    Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
    Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
    J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
    Ghosh M; Dutta S; Sanyal U
    Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
    Mukherjee A; Dutta S; Sanyal U
    J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
    Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
    Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
    Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)-1-methylhydrazines as anticancer agents.
    Sanyal U; De R; Dutta S; Das H; Ghost M
    Neoplasma; 1993; 40(4):219-22. PubMed ID: 8272148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
    Li Z; Yang Q; Qian X
    Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
    Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
    J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.